Inpharma Weekly

, Volume 1417, Issue 1, pp 19–19 | Cite as

Rosiglitazone: significant benefits in non-diabetic CAD

News item


Placebo Coronary Artery Disease Fibrinogen Rosiglitazone Thiazolidinedione 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2003

Personalised recommendations